Literature DB >> 26483125

Malaria Prevention Strategies: Adherence Among Boston Area Travelers Visiting Malaria-Endemic Countries.

Rhett J Stoney1, Lin H Chen2, Emily S Jentes2, Mary E Wilson2, Pauline V Han2, Christine M Benoit2, William B MacLeod2, Davidson H Hamer2, Elizabeth D Barnett.   

Abstract

We conducted a prospective cohort study to assess adherence to malaria chemoprophylaxis, reasons for nonadherence, and use of other personal protective measures against malaria. We included adults traveling to malaria-endemic countries who were prescribed malaria chemoprophylaxis during a pre-travel consultation at three travel clinics in the Boston area and who completed three or more surveys: pre-travel, at least one weekly during travel, and post-travel (2-4 weeks after return). Of 370 participants, 335 (91%) took malaria chemoprophylaxis at least once and reported any missed doses; 265 (79%) reported completing all doses during travel. Adherence was not affected by weekly versus daily chemoprophylaxis, travel purpose, or duration of travel. Reasons for nonadherence included forgetfulness, side effects, and not seeing mosquitoes. Main reasons for declining to take prescribed chemoprophylaxis were peer advice, low perceived risk, and not seeing mosquitoes. Of 368 travelers, 79% used insect repellent, 46% used a bed net, and 61% slept in air conditioning at least once. Because travelers may be persuaded to stop taking medication by peer pressure, not seeing mosquitoes, and adverse reactions to medications, clinicians should be prepared to address these barriers and to empower travelers with strategies to manage common side effects of antimalarial medications. © The American Society of Tropical Medicine and Hygiene.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26483125      PMCID: PMC4710418          DOI: 10.4269/ajtmh.15-0565

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  17 in total

1.  Choice of and adherence to prophylactic antimalarials.

Authors:  Larry Goodyer; Leanne Rice; Alan Martin
Journal:  J Travel Med       Date:  2011 Jul-Aug       Impact factor: 8.490

2.  Treatment of uncomplicated multidrug-resistant falciparum malaria with artesunate-atovaquone-proguanil.

Authors:  Michèle van Vugt; Elisabetta Leonardi; Lucy Phaipun; Thra Slight; Kyaw Lay Thway; Rose McGready; Alan Brockman; Leopoldo Villegas; Sornchai Looareesuwan; Nicholas J White; François Nosten
Journal:  Clin Infect Dis       Date:  2002-12-03       Impact factor: 9.079

3.  Combination atovaquone and proguanil hydrochloride vs. halofantrine for treatment of acute Plasmodium falciparum malaria in children.

Authors:  G Anabwani; C J Canfield; D B Hutchinson
Journal:  Pediatr Infect Dis J       Date:  1999-05       Impact factor: 2.129

4.  Assessment of adherence to atovaquone-proguanil prophylaxis in travelers.

Authors:  John C DePetrillo; Carol Singer; Isabella A Bergagnini; Patricia Kolakowski; Barbara Edwards; Miriam A Smith
Journal:  J Travel Med       Date:  2010 Jul-Aug       Impact factor: 8.490

Review 5.  Malaria chemoprophylaxis: strategies for risk groups.

Authors:  Patricia Schlagenhauf; Eskild Petersen
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

6.  Malaria risk perception, knowledge and prophylaxis practices among travellers of African ethnicity living in Paris and visiting their country of origin in sub-Saharan Africa.

Authors:  T Pistone; P Guibert; F Gay; D Malvy; K Ezzedine; M C Receveur; M Siriwardana; B Larouzé; O Bouchaud
Journal:  Trans R Soc Trop Med Hyg       Date:  2007-07-23       Impact factor: 2.184

7.  Trends in the knowledge, attitudes and practices of travel risk groups towards prevention of malaria: results from the Dutch Schiphol Airport Survey 2002 to 2009.

Authors:  Perry J J van Genderen; Pieter P A M van Thiel; Paul G H Mulder; David Overbosch
Journal:  Malar J       Date:  2012-05-29       Impact factor: 2.979

8.  Severity of imported malaria: protective effect of taking malaria chemoprophylaxis.

Authors:  Klaske Vliegenthart-Jongbloed; Mariana de Mendonça Melo; Marlies E van Wolfswinkel; Rob Koelewijn; Jaap J van Hellemond; Perry J J van Genderen
Journal:  Malar J       Date:  2013-07-31       Impact factor: 2.979

9.  Adherence to chemoprophylaxis and Plasmodium falciparum anti-circumsporozoite seroconversion in a prospective cohort study of Dutch short-term travelers.

Authors:  Sanne-Meike Belderok; Anneke van den Hoek; Will Roeffen; Robert Sauerwein; Gerard J B Sonder
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

10.  Imported malaria in Finland 2003-2011: prospective nationwide data with rechecked background information.

Authors:  Heli Siikamäki; Pia Kivelä; Outi Lyytikäinen; Anu Kantele
Journal:  Malar J       Date:  2013-03-14       Impact factor: 2.979

View more
  6 in total

1.  Malaria Disease and Chemoprophylaxis Usage among Israeli Travelers to Endemic Countries.

Authors:  Reut Harel; Bibiana Chazan; Eli Schwartz
Journal:  Am J Trop Med Hyg       Date:  2020-06       Impact factor: 2.345

Review 2.  Mefloquine for preventing malaria during travel to endemic areas.

Authors:  Maya Tickell-Painter; Nicola Maayan; Rachel Saunders; Cheryl Pace; David Sinclair
Journal:  Cochrane Database Syst Rev       Date:  2017-10-30

3.  Pre-travel malaria chemoprophylaxis counselling in a public travel medicine clinic in São Paulo, Brazil.

Authors:  Tânia do Socorro Souza Chaves; Wuelton Marcelo Monteiro; Jessé Reis Alves; Marcus Lacerda; Marta Heloisa Lopes
Journal:  Malar J       Date:  2017-02-07       Impact factor: 2.979

4.  Travelers' knowledge, attitudes, and behavior related to infectious diseases in Italy.

Authors:  Abdoulkader Ali Adou; Francesco Napolitano; Alessandra Vastola; Italo Francesco Angelillo
Journal:  PLoS One       Date:  2019-04-12       Impact factor: 3.240

5.  Malaria after international travel: a GeoSentinel analysis, 2003-2016.

Authors:  Kristina M Angelo; Michael Libman; Eric Caumes; Davidson H Hamer; Kevin C Kain; Karin Leder; Martin P Grobusch; Stefan H Hagmann; Phyllis Kozarsky; David G Lalloo; Poh-Lian Lim; Calvin Patimeteeporn; Philippe Gautret; Silvia Odolini; François Chappuis; Douglas H Esposito
Journal:  Malar J       Date:  2017-07-20       Impact factor: 2.979

6.  Imported malaria in the UK, 2005 to 2016: Estimates from primary care electronic health records.

Authors:  Hamad Bastaki; Louise Marston; Jackie Cassell; Greta Rait
Journal:  PLoS One       Date:  2018-12-31       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.